MedPath

Central Compartment Neck Dissection With Thyroidectomy

Not Applicable
Terminated
Conditions
Indeterminate Thyroid Nodules
Interventions
Procedure: Hemi-thyroidectomy + CLND
Procedure: Total thyroidectomy - CLND
Procedure: Total Thyroidectomy + CLND
Procedure: Hemi-thyroidectomy - CLND
Registration Number
NCT01106443
Lead Sponsor
University of Alberta
Brief Summary

When a patient presents with a thyroid mass, part of the work-up may include a fine needle aspiration biopsy (FNAB). The results of the biopsy then help plan treatment. If the results are benign, the management will typically be to follow the nodule. If the results demonstrate or are suspicious for cancer, such as papillary thyroid carcinoma (PTC), the treatment is a total thyroidectomy (total thyroid removal). The latest American thyroid association guidelines for PTC (2009) suggest that in many instances a central lymph node dissection (CLND) should be performed in conjunction with the total thyroidectomy. This procedure consists of removing the lymphatic (glandular) tissues surrounding the thyroid itself, as this tissue may have a propensity for cancer spread. The procedure's necessity has met much controversy in the last decade, but is becoming more of a standard in thyroid cancer surgery.

When a thyroid nodule FNAB is reported as indeterminate, the treatment strategy is less clear cut. While a diagnostic hemi-thyroidectomy or therapeutic total thyroidectomy may be in order, the inclusion of CLND is not clearly defined. In many centers a CLND will be omitted with surgical management for an "indeterminate" lesion, while in others, it is standard protocol. The argument of performing CLND is largely based on the tenet that it adds little surgical time, cost or risks to the patient. Because the evidence of the prognostic role of lymph node metastases is limited many would argue that the risk of not performing CLND is greater than performing CLND. Furthermore, in the event of finding cancer on final pathology, and thus, having to re-operate in the thyroid/central compartment bed, post-operative complications may increase. Opponents of CLND argue that there is a paucity of strong evidence supporting CLND in the improvement of oncologic outcomes and can potentially increase post-operative low calcium levels or vocal nerve damage However, these recommendations are based on retrospective level III evidence. Thus the debate continues: is CLND justified as an adjunct to hemi-or total thyroidectomy in indeterminate thyroid pathology?

The hypothesis is: CLND in hem- or total thyroidectomy for "indeterminate" thyroid nodules will not increase post-operative complications.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
128
Inclusion Criteria
  • Indeterminate or benign pathology on fine needle aspirate biopsy
  • Scheduled to undergo total or hemi-thyroidectomy
  • > 18 years old
Exclusion Criteria
  • Previous thyroid surgery
  • Previous neck surgery in field of thyroidectomy
  • Previous neck irradiation
  • Pre-operative hypocalcemia or hypoparathyroidism
  • Biopsy suggestive of thyroid cancer
  • Neck nodes suspicious for or with known cancer
  • Pre-operative vocal cord dysfunction

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Hemi-thyroidectomy + CLNDHemi-thyroidectomy + CLNDHemi-thyroidectomy with central lymph node dissection.
Total Thyroidectomy - CLNDTotal thyroidectomy - CLNDTotal thyroidectomy without central lymph node dissection.
Total Thyroidectomy +CLNDTotal Thyroidectomy + CLNDTotal thyroidectomy with central lymph node dissection.
Hemi-thyroidectomy - CLNDHemi-thyroidectomy - CLNDHemi-thyroidectomy without central lymph node dissection.
Primary Outcome Measures
NameTimeMethod
Short Term Hypo-calcemia< 1 month post-operatively

Definition: Serum Ionized Calcium (ICa) \< 0.9 mmol/L or symptoms related to hypocalcemia (acral or peri-oral paresthesia/numbness, tetany, muscle cramps/twitching, delirium etc.) and ICa \< 1.0 mmol/L

Secondary Outcome Measures
NameTimeMethod
Long Term Hypocalcemia> 1month

Definition: Serum Ionized Calcium (ICa) \< 0.9 mmol/L or symptoms related to hypocalcemia (acral or peri-oral paresthesia/numbness, tetany, muscle cramps/twitching, delirium etc.) and ICa \< 1.0 mmol/L

Vocal Cord Dysfunction1 month post-operatively

A surrogate for recurrent laryngeal nerve function. Determined pre- and post-operatively via flexible naso-pharyngoscopy (standard of care).

- evaluated by a validated measure (Voice Handicap Index)

Positive NodesAt the time of operation. (Time 0)

Presence of disease with in central lymph node dissection as per pathology report.

Surgical TimeDuring the operation. (Time 0)

Time from cutting skin to putting on last steri-strip on closed incision in the operating theatre.

Length of Hospital Stay1 day post-operatively on average

Days spent in the hospital post-operatively.

Trial Locations

Locations (2)

University of Alberta

🇨🇦

Edmonton, Alberta, Canada

Dalhouise University

🇨🇦

Halifax, Nova Scotia, Canada

© Copyright 2025. All Rights Reserved by MedPath